• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Crude Oil Down 4%; Aditxt Shares Spike Higher

    12/12/23 2:23:00 PM ET
    $ACHV
    $ADTX
    $CCCC
    $GGE
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACHV alert in real time by email

    U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 100 points on Tuesday.

    The Dow traded up 0.32% to 36,520.57 while the NASDAQ rose 0.46% to 14,498.23. The S&P 500 also rose, gaining, 0.26% to 4,634.47.

    Check This Out: Microsoft, U.S. Bancorp And 2 Other Stocks Insiders Are Selling

     

    Leading and Lagging Sectors

     

    Materials shares rose by 0.5% on Tuesday.

    In trading on Tuesday, energy shares fell by 1.7%.

     

    Top Headline

     

    Johnson Controls International plc (NYSE:JCI) reported weak results for its fourth quarter.

    Johnson Controls reported fourth-quarter FY23 sales growth of 2.7% year-on-year to $6.91 billion (+2% organically), missing the consensus of $7.09 billion. Adjusted EPS of $1.05 (+6% Y/Y) below the consensus of $1.09, according to Benzinga Pro.

     

    Equities Trading UP

     

    Aditxt, Inc. (NASDAQ:ADTX) shares shot up 64% to $6.25. Aditxt agreed to acquire Evofem Biosciences in consideration of the issuance of a combination of common stock and preferred stock and the assumption of certain senior indebtedness, having an aggregate amount of approximately $100 million.

    Shares of C4 Therapeutics, Inc. (NASDAQ:CCCC) got a boost, surging 108% to $2.45. C4 Therapeutics entered into an exclusive license and collaboration agreement with Merck & Co to develop degrader-antibody conjugates (DACs), an emerging modality designed to selectively target and neutralize disease-causing proteins in cancer cells.

    Icosavax, Inc. (NASDAQ:ICVX) shares were also up, gaining 48% to $15.49. AstraZeneca agreed to acquire Icosavax at $15.00 per share in cash at closing, plus a non-tradable contingent value right to receive up to $5.00 in cash, payable upon achievement of specified regulatory and net sales milestones.

     

    Equities Trading DOWN

     

    Achieve Life Sciences, Inc. (NASDAQ:ACHV) shares dropped 42% to $3.1350. Achieve Life Sciences said NDA Filing timing may be delayed to address FDA feedback on drug product candidate, Cytisinicline. Oppenheimer maintained Achieve Life Sciences with an Outperform and lowered the price target from $21 to $18.

    Shares of Oracle Corporation (NYSE:ORCL) were down 12% to $101.50. Oracle reported upbeat earnings for its second quarter, while sales missed estimates.

    Green Giant Inc. (NASDAQ:GGE) was down, falling 44% to $0.0850 as the company announced pricing of public offering.

    Also Check This Out: Don't Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts

     

    Commodities

     

    In commodity news, oil traded down 4.1% to $68.37 while gold traded up 0.1% at $1,994.70.

    Silver traded down 0.1% to $23.045 on Tuesday while copper rose 0.2% to $3.7880.

     

    Euro zone

     

    European shares closed lower today. The eurozone’s STOXX 600 fell 0.21%, London’s FTSE 100 fell 0.03% while Spain’s IBEX 35 Index fell 0.78% The German DAX fell 0.02% French CAC 40 fell 0.11%, while Italy’s FTSE MIB Index fell 0.28%.

    The ZEW Indicator of Economic Sentiment for the Eurozone surged by 9.2 points to 23 in December, recording the strongest reading in ten months, while German ZEW Indicator of Economic Sentiment rose to 12.8 in December from 9.8 in November.

    The number of job vacancies in the UK fell to 949,000 from September to November, while regular pay, excluding bonus payment in the UK, rose 7.3% year-over-year to GBP 620/week in the three months to October.

     

    Asia Pacific Markets

     

    Asian markets closed mostly higher on Tuesday, with Japan’s Nikkei 225 gaining 0.16%, Hong Kong’s Hang Seng Index gaining 1.07% and China’s Shanghai Composite Index gaining 0.40%. India’s S&P BSE Sensex, meanwhile, fell 0.54%.

    Producer prices in Japan increased 0.3% year-over-year in November following a revised 0.9% rise in October.

     

    Economics

     

    The NFIB Small Business Optimism Index declined for a fourth straight month to a reading of 90.6 in November.

    The annual inflation rate in the U.S. eased to 3.1% in November, recording the lowest reading in five months, compared to 3.2% in October.

    Now Read This: Top 5 Utilities Stocks That Should Keep You Up At Night

    Get the next $ACHV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACHV
    $ADTX
    $CCCC
    $GGE

    CompanyDatePrice TargetRatingAnalyst
    Oracle Corporation
    $ORCL
    2/9/2026Buy → Hold
    Melius
    Oracle Corporation
    $ORCL
    2/9/2026$180.00Neutral → Buy
    DA Davidson
    Oracle Corporation
    $ORCL
    2/4/2026$270.00 → $205.00Outperform
    BMO Capital Markets
    Oracle Corporation
    $ORCL
    1/12/2026$240.00Buy
    Goldman
    Johnson Controls International plc
    $JCI
    1/7/2026$148.00Hold → Buy
    Melius
    Oracle Corporation
    $ORCL
    12/11/2025$355.00 → $270.00Outperform
    BMO Capital Markets
    Oracle Corporation
    $ORCL
    12/3/2025$280.00Overweight
    Wells Fargo
    C4 Therapeutics Inc.
    $CCCC
    12/2/2025Buy
    TD Cowen
    More analyst ratings

    $ACHV
    $ADTX
    $CCCC
    $GGE
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by C4 Therapeutics Inc.

    SCHEDULE 13G/A - C4 Therapeutics, Inc. (0001662579) (Subject)

    2/11/26 12:58:54 PM ET
    $CCCC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form CERT filed by Oracle Corporation

    CERT - ORACLE CORP (0001341439) (Filer)

    2/5/26 4:24:57 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form 8-A12B filed by Oracle Corporation

    8-A12B - ORACLE CORP (0001341439) (Filer)

    2/5/26 4:18:28 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ACHV
    $ADTX
    $CCCC
    $GGE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Oracle Health Clinical AI Agent, Clinical Note Helps UK Doctors Spend More Time on Patient Care

    AI-powered agent for clinical notes is now available in the UK after demonstrating significant benefits at NHS Trusts Oracle Health Clinical AI Agent reduces documentation time, freeing time for more meaningful patient interaction LONDON, Feb. 12, 2026 /PRNewswire/ -- Following a successful pilot program at several NHS Trusts, Oracle Health today announced its Clinical AI Agent, Clinical Note is now available in the UK. The new AI solution allows caregivers at the NHS and private practices to use an ambient voice and screen-driven assistant to draft patient notes, so they can reduce administrative tasks and devote more time to patient care. Trusts participating in the pilot program, includin

    2/12/26 4:15:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Hillsboro Health Chooses AI-Powered Oracle Health Solutions to Help Advance Patient Care, Optimize Operations

    Will unify health record systems with Oracle Health Foundation EHR, implement Oracle Health Clinical AI Agent and Oracle Health Seamless Exchange across its network AUSTIN, Texas, Feb. 11, 2026 /PRNewswire/ -- Hillsboro Health, an independent, 25-bed critical access hospital based in Hillsboro, Illinois, has chosen Oracle Health solutions to help accelerate innovation, drive operational efficiencies, and enhance patient care. In addition to transitioning from legacy systems to an integrated Oracle Health Foundation EHR, Hillsboro Health plans to leverage Oracle Health Clinical AI Agent, an AI-powered, voice-driven solution, to automate clinical documentation and enable providers to dedicate

    2/11/26 8:05:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Cloud Infrastructure to Support Centers for Medicare and Medicaid's Modernization Initiative

    OCI to bolster federal health agency's mission critical systems AUSTIN, Texas, Feb. 11, 2026 /PRNewswire/ -- The Centers for Medicare & Medicaid Services (CMS) has selected Oracle Cloud Infrastructure (OCI) to consolidate and migrate select on-premises workloads to the cloud. OCI will support CMS' modernization efforts by providing secure, scalable cloud infrastructure for the agency's mission-critical systems. By migrating to OCI, CMS will leverage Oracle's FedRAMP® High-authorized infrastructure to meet the most stringent federal security and compliance requirements, along w

    2/11/26 8:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ACHV
    $ADTX
    $CCCC
    $GGE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Magouyrk Clayton M. sold $1,552,318 worth of shares (10,000 units at $155.23), decreasing direct ownership by 7% to 134,030 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    2/11/26 4:42:45 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    VP and President, Americas Grabowski Todd M sold $816,120 worth of Ordinary Shares (6,050 units at $134.90), decreasing direct ownership by 15% to 34,836 units (SEC Form 4)

    4 - Johnson Controls International plc (0000833444) (Issuer)

    2/10/26 11:41:28 AM ET
    $JCI
    Industrial Machinery/Components
    Industrials

    Director Vergnano Mark bought $1,011,320 worth of Ordinary Shares (7,665 units at $131.94), gifted 7,665 units of Ordinary Shares and received a gift of 7,665 units of Ordinary Shares (SEC Form 4)

    4 - Johnson Controls International plc (0000833444) (Issuer)

    2/5/26 6:32:15 PM ET
    $JCI
    Industrial Machinery/Components
    Industrials

    $ACHV
    $ADTX
    $CCCC
    $GGE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Vergnano Mark bought $1,011,320 worth of Ordinary Shares (7,665 units at $131.94), gifted 7,665 units of Ordinary Shares and received a gift of 7,665 units of Ordinary Shares (SEC Form 4)

    4 - Johnson Controls International plc (0000833444) (Issuer)

    2/5/26 6:32:15 PM ET
    $JCI
    Industrial Machinery/Components
    Industrials

    Director Fairhead Rona Alison bought $112,258 worth of shares (480 units at $233.87), increasing direct ownership by 2% to 22,110 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    7/9/25 4:39:51 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Director Boskin Michael J bought $111,145 worth of shares (1,682 units at $66.08), increasing direct ownership by 2% to 92,458 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    3/21/25 8:43:30 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ACHV
    $ADTX
    $CCCC
    $GGE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Oracle downgraded by Melius

    Melius downgraded Oracle from Buy to Hold

    2/9/26 9:24:14 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle upgraded by DA Davidson with a new price target

    DA Davidson upgraded Oracle from Neutral to Buy and set a new price target of $180.00

    2/9/26 6:56:02 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    BMO Capital Markets reiterated coverage on Oracle with a new price target

    BMO Capital Markets reiterated coverage of Oracle with a rating of Outperform and set a new price target of $205.00 from $270.00 previously

    2/4/26 7:57:19 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ACHV
    $ADTX
    $CCCC
    $GGE
    Financials

    Live finance-specific insights

    View All

    Johnson Controls Reports Strong Q1 Results; Raises FY26 Guidance

    Q1 sales increased 7% and organic sales increased 6%*Q1 GAAP EPS of $0.90; Q1 Adjusted EPS* of $0.89Q1 Orders +39% organically year-over-yearBacklog of $18.2 billion increased 20% organically year-over-year*  This earnings release contains non-GAAP financial measures. Definitions and reconciliations of the non-GAAP financial measures can be found in the attached footnotes. Non-GAAP measures should be considered in addition to, and not as replacements for, the most comparable GAAP measures.  CORK, Ireland, Feb. 4, 2026 /PRNewswire/ -- Johnson Controls International plc (NYSE:JCI), a global technology leader in energy efficiency, decarbonization, thermal management and mission-critical perform

    2/4/26 6:55:00 AM ET
    $JCI
    Industrial Machinery/Components
    Industrials

    Johnson Controls Announces First Quarter 2026 Earnings Conference Call Webcast

    CORK, Ireland, Jan. 12, 2026 /PRNewswire/ -- Johnson Controls International plc (NYSE:JCI), the global leader for smart, healthy and sustainable buildings, announces the following webcast:  What: Johnson Controls First Quarter Fiscal 2026 Earnings Conference Call When: Wednesday, Feb. 4, 2026, at 8:30 a.m. ET How: The conference call for investors can be accessed in the following ways: Live via webcast at http://investors.johnsoncontrols.com/news-and-events/events-and-presentations Note: A slide presentation will be available that morning for downloading.Live via telephone (for "listen-only" participants and those who would like to ask a question) by dialing 855-979-6654 (in the United State

    1/12/26 8:45:00 AM ET
    $JCI
    Industrial Machinery/Components
    Industrials

    Oracle Announces Fiscal Year 2026 Second Quarter Financial Results

    Q2 Remaining Performance Obligations $523 billion, up 438% in USDQ2 GAAP Earnings per Share up 91% to $2.10, Non-GAAP Earnings per Share up 54% to $2.26Q2 Total Revenue $16.1 billion, up 14% in USD and up 13% in constant currencyQ2 Cloud Revenue (IaaS plus SaaS) $8.0 billion, up 34% in USD and up 33% in constant currencyQ2 Cloud Infrastructure (IaaS) Revenue $4.1 billion, up 68% in USD and up 66% in constant currencyQ2 Cloud Application (SaaS) Revenue $3.9 billion, up 11% in both USD and constant currencyQ2 Fusion Cloud ERP (SaaS) Revenue $1.1 billion, up 18% in USD and up 17% in constant currencyQ2 NetSuite Cloud ERP (SaaS) Revenue $1.0 billion, up 13% in both USD and constant currencyAUSTI

    12/10/25 4:05:00 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ACHV
    $ADTX
    $CCCC
    $GGE
    Leadership Updates

    Live Leadership Updates

    View All

    Johnson Controls Appoints Susan Hughes to lead Asia Pacific Region

    Seasoned leader to strengthen execution and accelerate growth opportunities in the Asia Pacific region CORK, Ireland, Jan. 26, 2026 /PRNewswire/ -- Johnson Controls (NYSE:JCI), a global leader for smart, healthy and sustainable buildings, today announced the appointment of Susan Hughes as vice president and president, Asia Pacific. Hughes will report to CEO Joakim Weidemanis and join the company's executive committee. She succeeds Anu Rathninde, who will depart Johnson Controls at the end of February. "As we continue to operationalize our enterprise strategy, the Asia Pacific region represents a significant growth opportunity," said Joakim Weidemanis, CEO, Johnson Controls. "With her deep ex

    1/26/26 4:15:00 PM ET
    $JCI
    Industrial Machinery/Components
    Industrials

    Truelink Capital Announces Completion of Koch Filter Corporation Sale to Atmus Filtration Technologies and Names Azam Owaisi as CEO of Air Distribution Technologies

    LOS ANGELES and LOUISVILLE, Ky., Jan. 7, 2026 /PRNewswire/ -- Truelink Capital ("Truelink"), a Los Angeles-based private equity firm focused on growth and long-term value creation, today announced the completion of the sale of Koch Filter Corporation ("Koch Filter"), a leading provider of air filtration solutions and a subsidiary of Air Distribution Technologies, Inc. ("ADTi" or "Air Distribution Technologies"), to Atmus Filtration Technologies Inc. (NYSE:ATMU) ("Atmus Filtration Technologies" or "Atmus") for $450 million in cash. Founded in 1966, Koch Filter designs and manuf

    1/7/26 9:00:00 AM ET
    $ATMU
    $JCI
    Auto Parts:O.E.M.
    Consumer Discretionary
    Industrial Machinery/Components
    Industrials

    Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer

    SEATTLE and VANCOUVER, British Columbia, Oct. 20, 2025 (GLOBE NEWSWIRE) --  Achieve Life Sciences, Inc. (NASDAQ:ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline for treatment of nicotine dependence for smoking cessation, today announced the appointment of Erik Atkisson as Chief Legal Officer. In his new role, Mr. Atkisson will oversee Achieve's legal strategy, corporate governance, compliance, and risk management. "Erik's extensive legal, regulatory and M&A background in the biopharmaceutical sector provides valuable experience as we advance cytisinicline through regulatory review and prepare for a potential laun

    10/20/25 8:30:00 AM ET
    $ACHV
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ACHV
    $ADTX
    $CCCC
    $GGE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by C4 Therapeutics Inc.

    SC 13G/A - C4 Therapeutics, Inc. (0001662579) (Subject)

    11/14/24 7:53:04 PM ET
    $CCCC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by C4 Therapeutics Inc.

    SC 13G - C4 Therapeutics, Inc. (0001662579) (Subject)

    11/14/24 6:43:36 PM ET
    $CCCC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by C4 Therapeutics Inc.

    SC 13G/A - C4 Therapeutics, Inc. (0001662579) (Subject)

    11/14/24 4:05:17 PM ET
    $CCCC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care